Yi Hong Yao

Director Técnico/Científico/I+D en CELLULAR BIOMEDICINE GROUP, INC. .

59 años

Consumer Services

Health Technology

Perfil

Yi Hong Yao is currently Chief Scientific Officer at AbelZeta Pharma, Inc. since 2015.
Formerly, Dr. Yao was Director at MedImmune LLC from 2011 to 2015.
Education includes graduate studies at Boston University, a doctorate from the University of Kansas, and undergraduate studies at Fudan University.

Cargos activos de Yi Hong Yao

Empresas	Cargo	Inicio
CELLULAR BIOMEDICINE GROUP, INC.	Director Técnico/Científico/I+D	01/08/2015

Todos los cargos activos de Yi Hong Yao

Antiguos cargos conocidos de Yi Hong Yao.

Empresas	Cargo	Fin
MedImmune LLC MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Director/Miembro de la Junta	01/07/2015

Ver el detalle de la experiencia de Yi Hong Yao.

Formación de Yi Hong Yao.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Yi Hong Yao.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	5
MedImmune LLC MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Health Technology
Boston University Boston University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Kansas University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Fudan University Fudan University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
AbelZeta Pharma, Inc. AbelZeta Pharma, Inc. BiotechnologyHealth Technology Develops cell therapies to cure cancer and inflammatory & immunological diseases	Health Technology